Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Popp

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
The British Journal of Dermatology|September 2, 2018
Topical resiquimod dosing regimens in patients with multiple actinic keratoses: a multicentre, partly placebo-controlled, double-blind clinical trialE Stockfleth, G F L Hofbauer, U Reinhold, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 30, 2012
Randomized, double-blind, placebo-controlled study of safety and efficacy of miltefosine in antihistamine-resistant chronic spontaneous urticariaM Magerl, M Rother, T Bieber, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 25, 2025
KOH 5% solution versus diclofenac 3% for the treatment of actinic keratosis - Results from a three-armed RCTU Reinhold, N Leitz, R Dominicus, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
The British Journal of Dermatology|September 2, 2018
Topical resiquimod dosing regimens in patients with multiple actinic keratoses: a multicentre, partly placebo-controlled, double-blind clinical trialE Stockfleth, G F L Hofbauer, U Reinhold, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 30, 2012
Randomized, double-blind, placebo-controlled study of safety and efficacy of miltefosine in antihistamine-resistant chronic spontaneous urticariaM Magerl, M Rother, T Bieber, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 25, 2025
KOH 5% solution versus diclofenac 3% for the treatment of actinic keratosis - Results from a three-armed RCTU Reinhold, N Leitz, R Dominicus, et al.
Pageof 3